Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma

NCT00086034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma
Non-Hodgkin's Lymphoma

Interventions

DRUG: Motexafin gadolinium

Sponsor

Pharmacyclics LLC.